Renoprotective effects of a dipeptidyl peptidase 4 inhibitor in a mouse model of progressive renal fibrosis

Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts

(2016) Jianfeng Du et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Effect of Dipeptidyl Peptidase-4 Inhibitors on Plasma Adiponectin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

(2016) Amirhossein Sahebkar et al.   CURRENT MEDICINAL CHEMISTRY

Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis

(2015) Tracey Gaspari et al.   Diabetes & Vascular Disease Research

Glycosylation patterns of kidney proteins differ in rat diabetic nephropathy

(2015) Alessandra Ravidà et al.   KIDNEY INTERNATIONAL

A DPP-4 Inhibitor Suppresses Fibrosis and Inflammation on Experimental Autoimmune Myocarditis in Mice

(2015) Hiroyuki Hirakawa et al.   PLoS One

The potential for renoprotection with incretin-based drugs

(2014) Tetsuhiro Tanaka et al.   KIDNEY INTERNATIONAL

Dipeptidyl peptidase IV inhibitor protects against renal interstitial fibrosis in a mouse model of ureteral obstruction

(2014) Hye Sook Min et al.   LABORATORY INVESTIGATION

DPP-4 Inhibitor Attenuates Toxic Effects of Indoxyl Sulfate on Kidney Tubular Cells

(2014) Wei-Jie Wang et al.   PLoS One

Protection of Glucagon-Like Peptide-1 in Cisplatin-Induced Renal Injury Elucidates Gut-Kidney Connection

(2013) D. Katagiri et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Clinical and immunological implications of increase in CD208+ dendritic cells in tonsils of patients with immunoglobulin A nephropathy

(2013) H. Takechi et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Tissue Plasminogen Activator Activates NF- B through a Pathway Involving Annexin A2/CD11b and Integrin-Linked Kinase

(2012) L. Lin et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis

(2011) Zubair Shah et al.   CIRCULATION

Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome

(2011) D. Lamers et al.   DIABETES

Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice

(2011) J. Shirakawa et al.   DIABETES

Involvement of epimorphin in the repair of experimental renal fibrosis in mice

(2010) Muneharu Yamada et al.   LABORATORY INVESTIGATION

Effects of Sitagliptin Treatment on Dysmetabolism, Inflammation, and Oxidative Stress in an Animal Model of Type 2 Diabetes (ZDF Rat)

(2010) Liliana Ferreira et al.   MEDIATORS OF INFLAMMATION

Alteration in the phenotype of macrophages in the repair of renal interstitial fibrosis in mice

(2010) TAKETOSHI KUSHIYAMA et al.   NEPHROLOGY

Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice

(2008) Yusuke Moritoh et al.   EUROPEAN JOURNAL OF PHARMACOLOGY